CRISPR Therapeutics

In News

CRISPR Therapeutics Stock Is Absurdly Cheap -- Here's Why Analysts See 437% Upside Potential - The Motley Fool

The Motley Fool - Jun 03, 2026

Why Is CRISPR Therapeutics (CRSP) Down 0.7% Since Last Earnings Report? - Yahoo Finance

Yahoo Finance - Jun 03, 2026

CRISPR Therapeutics Stock Is Absurdly Cheap -- Here's Why Analysts See 437% Upside Potential - AOL.com

AOL.com - Jun 03, 2026

CRISPR Therapeutics (CRSP) grants 17,000 RSUs to general counsel - Stock Titan

Stock Titan - Jun 02, 2026

Eli Lilly Just Proved Gene Editing Could Be Pharma's Next Gold Rush -- but CRISPR Therapeutics Investors Should Watch Out - The Motley Fool

The Motley Fool - Jun 03, 2026

CRISPR Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire

GlobeNewswire - May 28, 2026

Eli Lilly Just Proved Gene Editing Could Be Pharma's Next Gold Rush -- but CRISPR Therapeutics Investors Should Watch Out - Yahoo Finance

Yahoo Finance - Jun 03, 2026

Assessing CRISPR Therapeutics (CRSP) Valuation After Casgevy Momentum And Gene Editing Pipeline Progress - simplywall.st

simplywall.st - May 29, 2026

Eli Lilly Just Proved Gene Editing Could Be Pharma's Next Gold Rush -- but CRISPR Therapeutics Investors Should Watch Out - AOL.com

AOL.com - Jun 03, 2026

CRISPR Therapeutics (CRSP) grants CMO Naimish Patel 22,000 RSUs vesting 2028 - Stock Titan

Stock Titan - Jun 02, 2026

CRISPR Therapeutics' Secret Weapon That Many Investors Are Overlooking - The Motley Fool

The Motley Fool - Jun 01, 2026

CRISPR Therapeutics' Secret Weapon That Many Investors Are Overlooking - Yahoo Finance

Yahoo Finance - Jun 01, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment